Assignee
CV THERAPEUTICS INC
US·100 granted patents·10 pending applications·2,808 citations·filing 1994–2008
Top patents by PatentIndex Score
110 records- 0198US7144872B2N-pyrazole A2A receptor agonistsCV THERAPEUTICS INC·Filed 2005·Granted Dec 5, 2006·50 cites·27 claims
- 0297US7553823B2C-pyrazole A2A receptor agonistsCV THERAPEUTICS INC·Filed 2006·Granted Jun 30, 2009·48 cites·8 claims
- 0396US7183264B2N-pyrazole A2A receptor agonistsCV THERAPEUTICS INC·Filed 2003·Granted Feb 27, 2007·48 cites·22 claims
- 0496US6825349B2A2B adenosine receptor antagonistsCV THERAPEUTICS INC·Filed 2002·Granted Nov 30, 2004·95 cites·31 claims
- 0596US6642210B12-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonistsCV THERAPEUTICS INC·Filed 2000·Granted Nov 4, 2003·61 cites·18 claims
- 0696US6552023B2Aralkyl substituted piperazine compoundsCV THERAPEUTICS INC·Filed 2001·Granted Apr 22, 2003·64 cites·24 claims
- 0796US6548548B2ABCA-1 elevating compoundsCV THERAPEUTICS INC·Filed 2001·Granted Apr 15, 2003·61 cites·39 claims
- 0896US6403567B1N-pyrazole A2A adenosine receptor agonistsCV THERAPEUTICS INC·Filed 1999·Granted Jun 11, 2002·112 cites·13 claims
- 0995US7317017B2A2B adenosine receptor antagonistsCV THERAPEUTICS INC·Filed 2005·Granted Jan 8, 2008·22 cites·15 claims
- 1095US7109180B2C-pyrazole A2A receptor agonistsCV THERAPEUTICS INC·Filed 2004·Granted Sep 19, 2006·43 cites·8 claims
- 1195US6770634B1C-pyrazole a2a receptor agonistsCV THERAPEUTICS INC·Filed 2000·Granted Aug 3, 2004·46 cites·6 claims
- 1295US6677336B2Substituted piperazine compoundsCV THERAPEUTICS INC·Filed 2001·Granted Jan 13, 2004·59 cites·34 claims
- 1395US6573264B1Heteroaryl alkyl piperazine derivativesCV THERAPEUTICS INC·Filed 2000·Granted Jun 3, 2003·60 cites·41 claims
- 1494US7160592B2Polymer coating for medical devicesCV THERAPEUTICS INC·Filed 2003·Granted Jan 9, 2007·211 cites·51 claims
- 1594US6977300B2A2B adenosine receptor antagonistsCV THERAPEUTICS INC·Filed 2003·Granted Dec 20, 2005·69 cites·25 claims
- 1694US6852724B2Sustained release ranolazine formulationsCV THERAPEUTICS INC·Filed 2003·Granted Feb 8, 2005·37 cites·17 claims
- 1794US6677342B2Partial fatty acid oxidation inhibitors in the treatment of congestive heart failureCV THERAPEUTICS INC·Filed 2002·Granted Jan 13, 2004·72 cites·20 claims
- 1894US6525057B2Sustained release ranolazine formulationsCV THERAPEUTICS INC·Filed 2001·Granted Feb 25, 2003·44 cites·12 claims
- 1994US6479496B1Methods for treating angina with ranolazineCV THERAPEUTICS INC·Filed 2000·Granted Nov 12, 2002·55 cites·10 claims
- 2094US5866702APurine inhibitors of cyclin dependent kinase 2CV THERAPEUTICS INC·Filed 1996·Granted Feb 2, 1999·142 cites·6 claims
- 2193US7582617B2Myocardial perfusion imaging methodCV THERAPEUTICS INC·Filed 2005·Granted Sep 1, 2009·27 cites·22 claims
- 2293US6794390B2Purine inhibitors of cyclin dependent kinase 2 & ikappabalphaCV THERAPEUTICS INC·Filed 2001·Granted Sep 21, 2004·43 cites·11 claims
- 2393US6620814B2Sustained release ranolazine formulationsCV THERAPEUTICS INC·Filed 2002·Granted Sep 16, 2003·35 cites·27 claims
- 2493US6617328B2Sustained release ranolazine formulationsCV THERAPEUTICS INC·Filed 2002·Granted Sep 9, 2003·32 cites·33 claims
- 2593US6605597B1Partial or full A1agonists-N-6 heterocyclic 5′-thio substituted adenosine derivativesCV THERAPEUTICS INC·Filed 1999·Granted Aug 12, 2003·97 cites·13 claims
- 2693US6503911B2Sustained release ranolazine formulationsCV THERAPEUTICS INC·Filed 2001·Granted Jan 7, 2003·36 cites·9 claims
- 2793US6369062B1Sustained release ranolazine formulationsCV THERAPEUTICS INC·Filed 2000·Granted Apr 9, 2002·37 cites·1 claims
- 2892US6451798B2Substituted alkyl piperazine derivativesCV THERAPEUTICS INC·Filed 2001·Granted Sep 17, 2002·26 cites·26 claims
- 2992US6294522B1N6 heterocyclic 8-modified adenosine derivativesCV THERAPEUTICS INC·Filed 1999·Granted Sep 25, 2001·122 cites·24 claims
- 3092US6214807B1C-pyrazole 2A A receptor agonistsCV THERAPEUTICS INC·Filed 1999·Granted Apr 10, 2001·74 cites·33 claims
- 3191US7125993B2A2B adenosine receptor antagonistsCV THERAPEUTICS INC·Filed 2003·Granted Oct 24, 2006·37 cites·47 claims
- 3291US6946449B2Partial and full agonists of A1 adenosine receptorsCV THERAPEUTICS INC·Filed 2002·Granted Sep 20, 2005·26 cites·30 claims
- 3391US6562826B1Sustained release ranolazine formulationsCV THERAPEUTICS INC·Filed 2002·Granted May 13, 2003·31 cites·26 claims
- 3491US6075150Aα-ketoamide inhibitors of 20S proteasomeCV THERAPEUTICS INC·Filed 1998·Granted Jun 13, 2000·96 cites·2 claims
- 3591US5789416AN6 mono heterocyclic substituted adenosine derivativesCV THERAPEUTICS INC·Filed 1996·Granted Aug 4, 1998·107 cites·14 claims
- 3690US6303607B1Method for administering a sustained release ranolanolazine formulationCV THERAPEUTICS INC·Filed 1999·Granted Oct 16, 2001·53 cites·2 claims
- 3788US7713946B2Partial and full agonists A1 adenosine receptorsCV THERAPEUTICS INC·Filed 2006·Granted May 11, 2010·12 cites·19 claims
- 3887US7521554B2A2B adenosine receptor antagonistsCV THERAPEUTICS INC·Filed 2006·Granted Apr 21, 2009·7 cites·5 claims
- 3987US7479485B2Method of treating arrhythmiasCV THERAPEUTICS INC·Filed 2005·Granted Jan 20, 2009·5 cites·5 claims
- 4087US6599283B1Method of preventing reperfusion injuryCV THERAPEUTICS INC·Filed 2001·Granted Jul 29, 2003·53 cites·10 claims
- 4186US7419709B2Polymer coating for medical devicesCV THERAPEUTICS INC·Filed 2006·Granted Sep 2, 2008·12 cites·5 claims
- 4286US7364768B2Polymer coating for medical devicesCV THERAPEUTICS INC·Filed 2006·Granted Apr 29, 2008·14 cites·15 claims
- 4386US7304070B2A2B adenosine receptor antagonistsCV THERAPEUTICS INC·Filed 2004·Granted Dec 4, 2007·23 cites·36 claims
- 4486US6818647B2Method and composition for restoring diuretic and renal functionCV THERAPEUTICS INC·Filed 2002·Granted Nov 16, 2004·16 cites·19 claims
- 4586US6528511B2Partial fatty acid oxidation inhibitors in the treatment of congestive heart failureCV THERAPEUTICS INC·Filed 2001·Granted Mar 4, 2003·22 cites·35 claims
- 4685US7271157B2A1 adenosine receptor agonistsCV THERAPEUTICS INC·Filed 2005·Granted Sep 18, 2007·7 cites·29 claims
- 4784US6821774B1Compositions and methods for increasing cholesterol efflux and raising HDL using ATP binding cassette transporter ABC1CV THERAPEUTICS INC·Filed 2000·Granted Nov 23, 2004·12 cites·9 claims
- 4884US6677343B2Substituted piperazine compoundsCV THERAPEUTICS INC·Filed 2001·Granted Jan 13, 2004·15 cites·25 claims
- 4984US6440948B1Thiophene A2A receptor agonistsCV THERAPEUTICS INC·Filed 2000·Granted Aug 27, 2002·19 cites·16 claims
- 5083US6900219B2ABCA-1 elevating compoundsCV THERAPEUTICS INC·Filed 2003·Granted May 31, 2005·23 cites·48 claims
Showing the top 50 of 110 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →